A new study highlights the potential of artificial DNA structures that, when fitted with antibodies, instruct the immune system to specifically target cancerous cells....
CAMBRIDGE, Mass., Aug. 10, 2023 /PRNewswire/ -- RTX's (NYSE: RTX) BBN division received a contract award to support DARPA's "In The Moment" program. ITM aims to develop the foundations...